|
Aug 8
|
Veracyte Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 7
|
Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care
|
|
Aug 6
|
Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates
|
|
Aug 6
|
Veracyte: Q2 Earnings Snapshot
|
|
Aug 6
|
Veracyte Announces Second Quarter 2025 Financial Results
|
|
Jul 31
|
Declining Stock and Decent Financials: Is The Market Wrong About Veracyte, Inc. (NASDAQ:VCYT)?
|
|
Jul 28
|
Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock?
|
|
Jul 26
|
Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion
|
|
Jul 24
|
Veracyte Set to Join S&P SmallCap 600
|
|
Jul 17
|
Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025
|
|
Jul 16
|
Should You Continue to Hold Veracyte Stock in Your Portfolio Now?
|
|
Jun 20
|
Veracyte (NASDAQ:VCYT) shareholders have earned a 19% return over the last year
|
|
Jun 6
|
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?
|
|
Apr 17
|
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
|
|
Apr 17
|
Should You Continue to Hold Veracyte Stock in Your Portfolio?
|
|
Apr 16
|
Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025
|
|
Apr 15
|
Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term
|
|
Apr 14
|
Here's Why Veracyte (VCYT) is a Strong Growth Stock
|
|
Apr 11
|
Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain?
|
|
Mar 13
|
Veracyte Stock Surges 45.6% in a Year: What's Driving the Rally?
|